Core Laboratories Inc. (NYSE:CLB - Get Free Report) declared a quarterly dividend on Wednesday, October 22nd. Investors of record on Monday, November 3rd will be paid a dividend of 0.01 per share by the oil and gas company on Monday, November 24th. This represents a c) dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date is Monday, November 3rd.
Core Laboratories has a dividend payout ratio of 4.7% indicating that its dividend is sufficiently covered by earnings. Analysts expect Core Laboratories to earn $1.11 per share next year, which means the company should continue to be able to cover its $0.04 annual dividend with an expected future payout ratio of 3.6%.
Core Laboratories Stock Up 6.4%
NYSE CLB opened at $12.81 on Thursday. The stock's 50 day moving average is $11.81 and its 200 day moving average is $11.74. The company has a current ratio of 2.27, a quick ratio of 1.70 and a debt-to-equity ratio of 0.47. Core Laboratories has a 12 month low of $9.72 and a 12 month high of $21.83. The stock has a market cap of $600.66 million, a PE ratio of 20.66, a P/E/G ratio of 6.66 and a beta of 1.38.
Core Laboratories (NYSE:CLB - Get Free Report) last posted its quarterly earnings results on Wednesday, October 22nd. The oil and gas company reported $0.22 EPS for the quarter, topping analysts' consensus estimates of $0.19 by $0.03. Core Laboratories had a return on equity of 14.15% and a net margin of 5.73%.The company had revenue of $134.52 million for the quarter, compared to analysts' expectations of $130.92 million. During the same period in the previous year, the firm earned $0.25 EPS. The firm's revenue was up .1% compared to the same quarter last year. Core Laboratories has set its Q4 2025 guidance at 0.180-0.22 EPS. Research analysts predict that Core Laboratories will post 0.96 EPS for the current fiscal year.
Institutional Inflows and Outflows
A number of large investors have recently bought and sold shares of the stock. Ariel Investments LLC lifted its holdings in Core Laboratories by 25.5% in the second quarter. Ariel Investments LLC now owns 12,976,463 shares of the oil and gas company's stock valued at $149,489,000 after acquiring an additional 2,634,438 shares during the period. Geode Capital Management LLC grew its holdings in Core Laboratories by 3.0% in the 2nd quarter. Geode Capital Management LLC now owns 1,114,560 shares of the oil and gas company's stock valued at $12,842,000 after buying an additional 32,934 shares in the last quarter. Fred Alger Management LLC lifted its stake in shares of Core Laboratories by 32.4% in the 1st quarter. Fred Alger Management LLC now owns 736,853 shares of the oil and gas company's stock valued at $11,045,000 after purchasing an additional 180,344 shares during the last quarter. Gendell Jeffrey L lifted its stake in shares of Core Laboratories by 24.6% in the 2nd quarter. Gendell Jeffrey L now owns 569,471 shares of the oil and gas company's stock valued at $6,560,000 after purchasing an additional 112,475 shares during the last quarter. Finally, Hotchkis & Wiley Capital Management LLC acquired a new position in shares of Core Laboratories in the 1st quarter valued at $6,008,000. 97.81% of the stock is owned by institutional investors and hedge funds.
Core Laboratories Company Profile
(
Get Free Report)
Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Core Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Core Laboratories wasn't on the list.
While Core Laboratories currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.